by admin | Jan 19, 2022 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
Reviewed by Emily Henderson, B.Sc. – Dec 16 2021 – News-Medical.net (link to article) The research group Immunology of Fungal Infections at the University of Valencia (UV) has investigated a fungal vaccine with which to train stem cells and hematopoietic...
by admin | Jan 18, 2022 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
Image caption: Human stem cells can be used to create models called blastoids (one shown that has been chemically altered to fluoresce) for studying how early-stage embryos implant into the lining of the uterus. Models of early-stage embryos could be used to research...
by admin | Jan 17, 2022 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
By Susan Buckles MayoClinic.com (link to article) Mayo Clinic has discovered how to microencapsulate pluripotent stem cells to potentially make them easier and less expensive to process and more effective for fighting disease. This research by Alexander Revzin, Ph.D.,...
by admin | Jan 15, 2022 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
By Alexandra Beckstett, The Horse Managing Editor, TheHorse.com (link to article) Indications for their use and how veterinarians choose between the two therapies. In recent years, there’s been tremendous interest in using regenerative therapies (or, more accurately,...
by admin | Jan 14, 2022 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
By Karen Weintraub – January 10, 2022 – APNews.com (link to article) A Maryland man has lived for three days with a pig heart beating inside his chest. The surgery, at the University of Maryland Medical Center, marks the first time a gene-edited pig has...
by admin | Jan 12, 2022 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
By: ALLISON GATLIN – Investors.com – 01/10/2022 (link to article) Pfizer (PFE) is entering the CRISPR space through a $1.35 billion deal with Beam Therapeutics (BEAM), the companies announced Monday. But Beam stock fell on the deal. Beam is using CRISPR...
